Clinical Trial Update: A Pilot Study of Metformin to Reduce Cerebrovascular Dysfunction in Participants With HIV and Metabolic Syndrome. [Phase 2]

View source ↗

Summary

Phase 2 pilot trial evaluating metformin to reduce cerebrovascular dysfunction in people with HIV and metabolic syndrome; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Metabolic Syndrome

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University of Stellenbosch | Conditions: Metabolic Syndrome, HIV Seropositivity | Phase 2 | Status: COMPLETED